RT Journal Article
SR Electronic
T1 N95 Mask Decontamination using Standard Hospital Sterilization Technologies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.05.20049346
DO 10.1101/2020.04.05.20049346
A1 Kumar, Anand
A1 Kasloff, Samantha B.
A1 Leung, Anders
A1 Cutts, Todd
A1 Strong, James E.
A1 Hills, Kevin
A1 Vazquez-Grande, Gloria
A1 Rush, Barret
A1 Lother, Sylvain
A1 Zarychanski, Ryan
A1 Krishnan, Jay
YR 2020
UL http://medrxiv.org/content/early/2020/04/20/2020.04.05.20049346.abstract
AB The response to the COVID-19 epidemic is generating severe shortages of personal protective equipment around the world. In particular, the supply of N95 respirator masks has become severely depleted, with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries. We sought to test the ability of 5 different decontamination methods: autoclave treatment, ethylene oxide gassing, low temperature hydrogen peroxide gas plasma treatment, vaporous hydrogen peroxide exposure and peracetic acid dry fogging to decontaminate a variety of different N95 masks of experimental contamination with SARS-CoV-2 or Vesicular stomatitis virus as a surrogate. In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity. We found that one cycle of treatment with all modalities was effective in decontamination and was associated with no structural or functional deterioration. Vaporous hydrogen peroxide, peracetic acid dry fogging and autoclave treatments were associated with no loss of structural or functional integrity to a minimum of 10 cycles for the mask models tested. The molded N95 masks however tolerated only 1 cycle of autoclaving. The successful application of autoclaving for layered fabric, pleated masks may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was not supported by any external fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall manuscript data is available for review.